STERIS VP gets stock, options in equity award

STERIS plc senior vice president Julia Madsen reported routine equity compensation activity.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

STERIS plc senior vice president Julia Madsen reported routine equity compensation activity. She received 2,316 ordinary shares as a stock award and a new employee stock option covering 8,080 ordinary shares at an exercise price of $230.74 per share, expiring on June 2, 2036. To cover tax obligations on 352 restricted shares that vested on June 2, 2026, 127 shares were withheld by the company, which is recorded as a tax-withholding disposition rather than an open-market sale. After these transactions, she holds 12,691 ordinary shares directly, of which 5,398 are restricted shares scheduled to vest in tranches between June 2026 and June 2029.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Madsen Julia

Role Sr. VP and GM, Life Sciences

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	8,080	$0.00	$0.00
Grant/Award	Ordinary Shares	2,316	$0.00	$0.00
Exercise Price or Tax Liability	Ordinary Shares	127	$209.76	$27K

Holdings After Transaction: Employee Stock Option (right to buy) — 8,080 contracts (Direct); Ordinary Shares — 12,691 shares (Direct)

Footnotes (3)

F1. As of June 2, 2026, 5,398 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 666 on June 3, 2026; 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.
F2. 127 shares were withheld from the 352 restricted shares that vested on June 2, 2026. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
F3. This option becomes exercisable as follows: 2,020 on June 2, 2027, 2,020 on June 2, 2028, 2,020 on June 4, 2029 and 2,020 on June 3, 2030.

Key Figures

Stock award: 2,316 ordinary shares Option grant size: 8,080 shares Option exercise price: $230.74 per share +4 more

7 metrics

Stock award 2,316 ordinary shares Grant/award acquisition on June 2, 2026

Option grant size 8,080 shares Employee stock option covering ordinary shares

Option exercise price $230.74 per share Employee stock option strike price

Option expiration June 2, 2036 Employee stock option expiration date

Tax-withheld shares 127 shares Shares withheld from 352 vested restricted shares for taxes

Direct holdings after award 12,818 ordinary shares Total direct shares following non-derivative award

Restricted shares outstanding 5,398 ordinary shares Restricted portion of holdings as of June 2, 2026

Key Terms

restricted shares, Employee Stock Option (right to buy), tax-withholding disposition, NYSE closing market price, +1 more

5 terms

restricted shares financial

"As of June 2, 2026, 5,398 of these ordinary shares are restricted."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy) with underlying ordinary shares."

tax-withholding disposition financial

"127 shares were withheld... represent the value of the taxes required to be withheld."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 2, 2026."

grant, award, or other acquisition financial

"Transaction code description: Grant, award, or other acquisition."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did STERIS (STE) executive Julia Madsen receive?

Julia Madsen received 2,316 ordinary shares and a stock option for 8,080 shares. The option has an exercise price of $230.74 per share and expires on June 2, 2036, reflecting routine compensation rather than open-market buying.

How many STERIS (STE) shares does Julia Madsen hold after these transactions?

After the transactions, Julia Madsen directly holds 12,818 STERIS ordinary shares. This balance includes both unrestricted and 5,398 restricted shares that will vest in several installments between June 2026 and June 2029, according to the filing footnotes.

Why were 127 STERIS (STE) shares disposed of in Julia Madsen’s Form 4?

127 shares were withheld to satisfy tax obligations on vesting restricted shares. These shares came from 352 restricted shares that vested on June 2, 2026, and were valued at the NYSE closing market price that day for required employment and tax withholding.

Are Julia Madsen’s STERIS (STE) transactions open-market buys or sells?

The filing shows compensation-related grants and tax withholding, not open-market trades. The acquisitions reflect stock and option awards, while the 127-share disposition is a tax-withholding entry, indicating no discretionary market purchase or sale activity in this report.

When do Julia Madsen’s new STERIS (STE) stock options vest and expire?

The 8,080-share option vests in four equal installments and expires in 2036. Vesting occurs in blocks of 2,020 shares on June 2, 2027, June 2, 2028, June 4, 2029, and June 3, 2030, with expiration on June 2, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/04/2026 - 04:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Madsen Julia

(Last)

(First)

(Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2

D02 R296

(City)

(State)

(Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr. VP and GM, Life Sciences

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	06/02/2026		A		2,316	A	$0	12,818⁽¹⁾	D
Ordinary Shares	06/02/2026		F		127⁽²⁾	D	$209.76	12,691⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$230.74	06/02/2026		A		8,080		⁽³⁾	06/02/2036	Ordinary Shares	8,080	$0	8,080	D

Explanation of Responses:

1. As of June 2, 2026, 5,398 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 666 on June 3, 2026; 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

2. 127 shares were withheld from the 352 restricted shares that vested on June 2, 2026. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

3. This option becomes exercisable as follows: 2,020 on June 2, 2027, 2,020 on June 2, 2028, 2,020 on June 4, 2029 and 2,020 on June 3, 2030.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR